SEC Filing Summary

This filing details a transaction by Raymon Heather, SVP of Research and Development at Artiva Biotherapeutics, Inc. On May 19, 2026, Heather disposed of 3,095 shares of common stock with a post-transaction share count of 148,228. The disposal was part of a "sell-to-cover" policy to satisfy tax withholding obligations related to the vesting of restricted stock units. The sales were automatic and not at Heather's discretion. The weighted average sale price was $9.0078, with prices ranging from $8.7447 to $9.0104. Full details on shares sold at each specific price will be provided upon request.